1 周世明,贾杰.抗结核药物致药物性肝病208例临床分析[J].中国热带医学,2004,4(2): 181-1832 方毅敏,陈志成,潘四珍.异烟肼利福平吡嗪酰胺对结核病患者肝功能的影响[J].实用医学杂志,1997,(9) :609-6103 Dossing M,Wilcke JTR, Askgaard DS,et al. Liver injury during antituberculosis treatment : an 11-year study [J].Tuber lung Dis,1996,77(4):335-3404 Steele MA, Bark RF, DesPrez RM. Toxic hepatitis with isonia-zid and rifampicim. A meta analysis[J]. Chest, 1991,99:465-4715 Teleman MD,Chee CBE, Earnest A, et al. Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore[J]. Int Tuberc Lung Dis,2002,6(8):699-7056 Centres for Disease Contral. Fatal and severe hepatitis associated with rifampicin and pyrazinamide for the treatment of latent tu-berculosis infection-New York and Georgia[J]. MMWR Week-ly 20, 2001,50(15) :289-2917 Centers for Disease Control and Prevention. Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in the American Thoracic Society/CDC recommendations-United States[J]. Am J. Respir.Crit. Care Med, 2001,164:1319-13208 Mitchell I, Wendon J, Fitt S,et al. Anti-tubcrculous therapy and acute liver failure[J]. Lancet, 1995,345:555-5569 Moulding TS, Redeker AG,Kanel GC. Acetaminophen,isonia-zidtand hepatic toxicity[J]. Ann Int Med, 1991,114 :43110 张敦熔,编.现代结核病学[M]北京:人民军医出版社,2000,646-64911 张培元.应重视肝脏疾患时抗结核药物肝损害[J].中华结核和呼吸杂志,1998,21(11) :643-64412 郑道武.抗结核药物所致急性肝坏死6例报告[J].中国防痨杂志,1996,18(4):18813 余自力,赵烈炎,袁朝伟.抗结核药物对抗HCV抗体阳性患者肝功能的影响[J].中国防痨杂志,1993,15(4):17714 邱鸣,杜荣辉.酒精性肝病抗痨方案选择[J].中华结核和呼吸杂志,2003,26(9):572-57315 Lee BH, Koh WJ, Choi MS, et al. Inactive hepatitis B surface antigen carrier state and heap totoxicity during antituberculosis chemotherapy[J]. Chest,2005,127(4) : 1304-131116 朱苏宝,杨齐英,张建平.2HRS(E)Z/4HR方案对肺结核合并乙肝阳性忠者肝功能的影响[J].临床肺科杂志,2002, 7(4):42-4317 Harada H,Murai S, Kojima H,et al. Diagnosis and treatment of pulmonary tuberculosis complicated with chronic liver disease [J]. Nippon Rinsho,1998,56(12) ,3212-321618 Cosling RD, Uiso LO, Sam NE, et al. The bactericidal activity of moxifloxacin in patients with pulmonary tubercuIosis[J]. Am J Respir Crit Care Med,2003,168: 134219 Hu Y, Coates ARM, Mitchison DA. Sterlizing activities of flu-oroquinolones against rifampin-tolerant populations of myco-bacterium tuberculosis[J]. Antimi-crobial Agents and Chemo-therapy,2003,47 :65320 许申,邝荔香,昝义东,等.结核清联用方案治疗难治肺结核32例的疗效观察及血药浓度的检测[J].中国防痨杂志,1999,21⑶:169-17021 孙丽,席家宁,康丽君,等.对氨基水杨酸好烟肼对耐INH及PAS结核菌株的耐药实验观察[J].中国防痨杂志,2001, 23(2):110-11122 Bagnato GF, Di Cesare E,Gulli S, et al. Long-term treatment of pulmonary tuberculosis with ofloxacin in a subject with liver cirrhosis[J]. Monaldi Arch chest Dis, 1996,51 (2) : 159-16023 Saigal S, Agarwal SR. Safety of an ofloxacin-based antitubercu-lar regimen for the treatment of tuberculosis in patient with un-derlying chronic liver disease [J]. J Gastroenterol Hepatoc,2001,16(9) ,1028-103224 王虹,赵旺胜,杨正安,等.伴有肝功能异常的肺结核的化学治疗[J].江苏医药,2000,26(9)25 林志来,施振慧,翁恒,等.“力克菲蒺、利福喷汀、阿米卡星、左氧氟沙星”方案对肝损害肺钻核疗效及安全性观察[J].中国防痨杂志,2006,28⑷:238-241 |